CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

66 hedge funds and large institutions have $44.3M invested in Cascadian Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.3M
Puts
$409K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
26
$259K
27
$250K
28
$243K
29
$192K
30
$127K
31
$126K
32
$111K
33
$88K
34
$78K
35
$75K
36
$70K
37
$61.4K
38
$59K
39
$57K
40
$54K
41
$51K
42
$46K
43
$46K
44
$46K
45
$45K
46
$42K
47
$42K
48
$40K
49
$39K
50
$38K